{"paper_id":"7539e06e-7b58-4f02-a8a9-605f2cebef9d","body_text":"Reference\nPokrzywinski RM, et al. Impact of elagolix on work loss due to endometriosis-associated pain: estimates based on the results of two phase III clinical trials. Fertility and Sterility : 18 Jun 2019. Available from: URL: http://doi.org/10.1016/j.fertnstert.2019.04.031\nRights and permissions\nAbout this article\nCite this article\nElegolix reduces endometriosis-related work loss, saves costs. PharmacoEcon Outcomes News 832, 11 (2019). https://doi.org/10.1007/s40274-019-6037-9\nPublished:\nVersion of record:\nIssue date:\nDOI: https://doi.org/10.1007/s40274-019-6037-9","source_license":"CC0","license_restricted":false}